{
  "1": {
    "premise": "Patient (52M), currently on holiday, presents with several months' history of nasal congestion (blocked, crusty), generalized fatigue, and widespread myalgia. Reports feeling generally unwell.",
    "statement": "Granulomatosis with polyangiitis (GPA) cannot be ruled out, and while it may be unlikely, the symptoms are consistent with the condition and warrant evaluation due to the potential for serious harm if left untreated.",
    "label": true
  },
  "2": {
    "premise": "A 40-year-old female presents with a mild fever and pain localized to the renal angle. She denies any coughing and her pulse is within normal limits. Based on her symptoms, she suspects she may have pyelonephritis.",
    "statement": "Pneumonia cannot be completely ruled out; although less likely, lower lobe involvement remains a potential risk given the location of the pain and should warrant evaluation due to the potential for serious harm if left untreated.",
    "label": true
  },
  "3": {
    "premise": "Patient presents with clinical features suggestive of meningitis. Currently hemodynamically stable, afebrile, and alert. No signs of raised intracranial pressure on examination. Lumbar puncture was attempted but unsuccessful. Discussed with Consultant Dr. A. Smith, who reviewed the case and, given the patient’s stability and presumed viral etiology, advised deferring the procedure. Empirical antiviral therapy was initiated. No antibiotics started at this stage. Plan for lumbar puncture to be performed by senior consultant on 06/07/2025.",
    "statement": "Bacterial meningitis has not been ruled out, and deferring lumbar puncture and antibiotic treatment poses a significant risk if the infection is bacterial in origin.",
    "label": true
  },
  "4": {
    "premise": "A 45-year-old man with a known shellfish allergy experienced an episode of anaphylaxis after dining at a restaurant. Shortly after eating, he developed breathing difficulty and collapsed. He was administered intramuscular epinephrine at the scene but lost consciousness. Witnesses reported tonic-clonic movements and urinary incontinence during the episode. He was taken to the emergency department, where he received intravenous adrenaline and supportive care.",
    "statement": "The episode involved seizure-like activity including tonic-clonic movements and incontinence, so referral to a First Seizure (FIT) clinic is appropriate to assess for underlying neurological risk.",
    "label": true
  },
  "5": {
    "premise": "Adverse Events: A 72-year-old patient receiving chemotherapy developed febrile neutropenia on Day 10 of Cycle 1. Temperature was 38.6°C, absolute neutrophil count (ANC) 0.2 x10⁹/L. Managed as outpatient with oral antibiotics. No hospital admission or IV antibiotics were arranged. Patient monitored via phone follow-up.",
    "statement": "This patient’s febrile neutropenia should have been managed with hospital admission and IV antibiotics, as outpatient oral treatment is unsafe in high-risk cases like this.",
    "label": true
  },
  "6": {
    "premise": [
      "Adverse Events 1:",
      "  Total: 35/51 (68.63%)",
      "  Constipation 20/51 (39.22%)",
      "  Blood disorder 1/51 (1.96%)",
      "  Hypomagnesemia 1/51 (1.96%)",
      "  Platelets count decrease 1/51 (1.96%)",
      "  Thrombosis 6/51 (11.7%)",
      "  Vision-blurred vision 1/51 (1.96%)",
      "  Radiation oesophagitis 1/51 (1.96%)",
      "  Nausea 2/51 (3.92%)",
      "  Vomiting 2/51 (3.92%)",
      "  General symptom 2/51 (3.92%)",
      "  Headache 1/51 (1.96%)",
      "  Bone pain 1/51 (1.96%)"
    ],
    "statement": "Although less common, thrombosis represents a higher patient risk than constipation due to its greater potential for serious harm.",
    "label": true
  },
  "7": {
    "premise": [
      "Adverse Events 2:",
      "  Total: 40/60 (66.67%)",
      "  Fatigue 25/60 (41.67%)",
      "  Anaphylaxis 3/60 (5.00%)",
      "  Injection site reaction 4/60 (6.67%)",
      "  Rash 2/60 (3.33%)",
      "  Headache 3/60 (5.00%)",
      "  Dizziness 2/60 (3.33%)",
      "  Mild hypotension 1/60 (1.67%)"
    ],
    "statement": "Although less frequent, anaphylaxis poses a greater patient risk than fatigue because of its life-threatening nature.",
    "label": true
  },
  "8": {
    "premise": [
      "Adverse Events 3:",
      "  Total: 28/55 (50.91%)",
      "  Dry mouth 18/55 (32.73%)",
      "  Bradycardia 2/55 (3.64%)",
      "  Syncope 1/55 (1.82%)",
      "  Transient dizziness 3/55 (5.45%)",
      "  Injection site reaction 2/55 (3.64%)",
      "  Anxiety 1/55 (1.82%)",
      "  Fatigue 1/55 (1.82%)"
    ],
    "statement": "Although dry mouth was more common, bradycardia represents a higher patient risk due to its impact on cardiac function.",
    "label": true
  },
  "9": {
    "premise": [
      "Adverse Events 7:",
      "  Total: 50/70 (71.43%)",
      "  Injection site pain 20/70 (28.57%)",
      "  Myocardial infarction 3/70 (4.29%)",
      "  Hypertensive crisis 5/70 (7.14%)",
      "  Seizure 2/70 (2.86%)",
      "  Dizziness 3/70 (4.29%)",
      "  Nausea 2/70 (2.86%)"
    ],
    "statement": "Although more patients experienced injection site pain, myocardial infarction carries a far higher risk due to its severity and potential for fatal outcomes.",
    "label": true
  },
  "10": {
    "premise": [
      "Adverse Events 8:",
      "  Total: 55/80 (68.75%)",
      "  Fatigue 25/80 (31.25%)",
      "  Anaphylaxis 3/80 (3.75%)",
      "  Respiratory distress 5/80 (6.25%)",
      "  Hypotension 4/80 (5.00%)",
      "  Diarrhea 4/80 (5.00%)",
      "  Rash 3/80 (3.75%)"
    ],
    "statement": "Although fatigue was more frequent, anaphylaxis presents a greater risk due to its potential to cause life-threatening airway obstruction or shock.",
    "label": true
  }
}
